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Center for Research & Grants

R e s e a rc h M at t e r s

Welcome…
This is the first edition of Research Matters, a quarterly e-newsletter brought to you
by the Center for Research & Grants. For those who are not aware of the resources the
Center provides to the Baptist Health South Florida community, we have included a list
of our services on the last page of this newsletter. Research Matters is intended to be
an educational tool to: A) Provide information about industry trends, standards and
guidelines that could impact how we conduct research at Baptist Health South Florida
(BHSF), B) Disseminate information about BHSF research initiatives and policies
throughout the system, and C) Inform researchers, and those who want to do research,
about the resources BHSF has available. Each edition will provide regular features
covering Industry News Updates, Research Compliance, Grants Updates, Library
Services, a quarterly Education Calendar and more. We welcome volunteer guest
columnists as well as suggestions for research topics that you would like to hear about.
For example, if you would like to write an editorial about the Sunshine Act and
how it might impact doing research at BHSF, we would like to hear from
you. Please send Debbie Eyerdam (deborahey@baptisthealth.net) or Jossy
Sanchez (josefinasa@baptisthealth.net) your questions, comments and
suggestions. We look forward to working together on Research
Matters.
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Library Services
Looking for literature to
support your research
project? Any Baptist Health
staff member may use library
resources for the
improvement of quality of
care of patients. Library
services support patient care,
evidence based practice,

continuing education,
research and publications,
and management. Services
include: computerized
literature searches on
MEDLINE, CINAHL and
other evidence-based health
and business databases;
document delivery to users

electronically by e-mail, fax,
photocopy or mail ; access to
core reference and journal
collection; circulation and
interlibrary loan of
books, and DVDS for
ongoing learning; electronic
access to OVID MEDLINE
and other databases and
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Cont’d Library Services...
e-textbooks and e-journals (from
offices and home, after library
hours, using the ATHENS portal);
and educating library users
regarding effective searching for
evidence based resources, relative
to the provision of excellent
health care to patients.

T h e G r a n t s Te a m

Allison Bivin

David Puente

Wish you had access to funding to help support your program or research
project but don’t know where to turn to for help? Look no further, Baptist
Health has a team of dedicated professionals to help you apply for grant
funding. The Grants Team is here for you and will help you every step of the
way in the pre- and post-award process. Serving the Baptist Health system
and its employees, our subject matter experts have the experience to assist
you in developing your research or program initiative, look for appropriate
federal, state, local or foundation funding, guide you through the application
process, compose and edit your proposal, build your budget, create an
advisory board and timeline for your project, assist you in managing the
award once awarded and much more!
To learn about our wrap-around services or if you are ready to make a
difference at Baptist Health and take the lead on a research or program
launch, please email us at grantsinfo@baptisthealth.net.

Karen Holmes

EDC and EMR leading to increased
remote monitoring – are we ready?
By Jacqueline Mejias, BS, LPN, CCRC, CCRP

The use of Electronic Medical Records (EMR) by sites and
Electronic Data Capture (EDC) by sponsors will inevitably
lead to increased remote monitoring instead of, or in
addition to, the traditional on site monitoring visits. In
August 2011 the FDA issued a guidance titled “Guidance for
Industry Oversight of Clinical Trial Investigations- A Risk
Based Approach to Monitoring” in which it details the
different monitoring methods that can be used while
maintaining human subject protection and quality of clinical
trial data as a top priority. (Walker, 2011)
The previous FDA guidance on monitoring issued January

1988 stated “the most effective way to monitor a trial was to
maintain personal contact between the monitor and the
investigator throughout the clinical investigation.” (FDA,
2011) The new guidance is in keeping with the technological
advances and changes in communication. Email, webcasts,
and online training modules are commonplace and already a
large part of sites communicating with sponsors. Remote
monitoring would be an extension of that communication.
It has been my experience that currently sponsors utilize a
combination of on site and remote monitoring depending on
complexity of clinical trial, data analysis deadlines, staff
knowledge and experience. The first visit is usually done in
person and if the monitor feels the site knows what they are
doing then subsequent visits may be done remotely.
Changes in staff, protocol amendments, or lack of
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enrollment may require on site visits.

requirements.

The staff site will need to keep in mind the potential cost of
remote monitoring. The initial study agreement needs to
clearly define what will be expected of monitors, coordinators
and the Principal Investigator (PI) to make sure budget reflects
the hours allocated for monitoring or a mechanism for
invoicing. It is not uncommon for a coordinator to dedicate
extensive hours completing EDC forms and then be asked for
additional information via phone, email or data queries within
EDC system as preparation for a monitoring visit - remote or
on site.

It is clear that “no single approach to monitoring is appropriate or
necessary for every clinical trial.” (FDA, 2011) It is important to
keep in mind that changes in technology will have an impact on
clinical trials overall not just with monitoring. At the site level,
being open to interactions whether it is via email, online chat,
phone or in person will allow for a successful trial.

The guidance documents issued by the FDA are the current
thinking on the topic and provide suggestions or
recommendations but not legally enforceable responsibilities or

Walker, E. P. (2011, September 02). FDA says Industry Should Monitor Trials
Remotely. Retrieved from Med Page Today : http://www.medpagetoday.com/
PublicHealthPolicy/ClinicalTrials/28344
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Is Social Networking a Medical Breakthrough or a Media Disaster?
By Ivette De Pool, B.A.
Having jumped from 50 million users in 2007 to 800 million
in 2011, Facebook™ is now the largest social networking site
in the world, according to company figures. With a quick
click of the mouse and its vast array of services, users are able
to connect within seconds. Facebook™ has the ability to keep
users on its site for hours every day by providing features such
as music streaming, advertising, delivery of the latest news
and more. The evidence is clear, in less than a decade, this
spaghetti digital connection has ballooned into a giant corporate social web, encouraging users to find new ways to communicate and share information.
Medical professionals are not exempt from using this technology for the betterment or detriment of their careers. Doctors, nurses and researchers alike often consider social media
as a way to exhibit their knowledge and educate those who are
interested. Therefore, social networking can be beneficial for
patients. Networking allows patients to share personal experiences and learn about treatment options based on similar illnesses and experiences. Also, networking can empower patients to take control of their health care decisions. An informed patient, leads to a rise in patient/provider relations,
which in turn leads to healthier individuals overall. “Fiftyseven percent of Americans surf the web for health-related
information”, reports The Pew Research Center in Washington, D.C.
Moreover, pharmaceutical companies are also learning fairly
quickly that networking has become a sure fire way to recruit
participants for clinical trials. Recruitment is one of the biggest obstacles that pharmaceutical companies face when initiating a study. The issue is that they are never able to reach
certain demographics. Social networking is able to open the
door to specific groups and allow participant quotas to be met
in a timely manner. Scott Connor, VP of Marketing for Acu-

rian, a clinical trial patient recruitment and retention provider
explains, “The Facebook™ ad network can display a clinical
trial message to those Facebook™ users that you only want to
target, say, women aged 40-54 for your female incontinent
study and then you can narrow it further to only those women
who live within 25 miles of your active clinical trial site.”
The downside that stems from networking sites is that of privacy. How much of it do we have, or not? Keep in mind that
once something is posted online, it never goes away. Ryan
Greysen, M.D., M. A,
Clinical Scholar of the
Robert Wood Johnson
Foundation reiterates that,
“physicians may not consider the potential impact
of their online content on
their patients and the public. A momentary lapse in judgment by an individual physician
to create unprofessional content online can reflect poorly on
the entire profession.” HIPAA Privacy Rule protects the patient’s health information, which is, “all individually identifiable health information held or transmitted by a covered entity or its business associate, in any form or media, whether
electronic, paper or oral.” 45C.F.R 160.103.
Networking sites are designed for just that, to network.
When using or posting something on a social networking site,
take a moment and think. Would this be considered a HIPAA
violation? Take precaution and be responsible for the use of
social media because it can be a blessing if used properly, and
a detriment if not. Remember, if you would not say it in an
elevator, you certainly should not post it online.
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What the Final Rule on FCOI in Research Means to BHSF investigators and Research Staff
By Ofer Amit, MSEM, CHRC, Research Compliance Administrator
The Department of Health and Human Services (HHS) has
announced a Final Rule, that lays out Public Health Service
(PHS) requirements relating to Individual Financial Conflict of
Interest (FCOI) in research. Although the existing rule and the
Final Rule are similar, the Final Rule includes new provisions
and changes to existing requirements. Among the changes,
are a revised definition of the term Significant Financial Interest (SFI), the addition of training requirements, expansion of
the scope of required disclosures, and the inclusion of specific
reporting and public disclosure requirements. Compliance
with the Rule is required by August 24, 2012.
Research institutions, sponsors, and governing bodies are
aware of the ethical concerns that financial interests of investigators and key research personnel can bring to bear. Most are
cognizant of the effect conflicting financial interests for researchers (whether real or perceived) could have on the
value, integrity and reputation of their research programs. To
this end, the Food and Drug Administration (FDA) lays out its
own criteria for the disclosure of financial interests of Clinical
Investigators conducting a Covered Clinical Study. The Common Rule prohibits participation of Institutional Review Board
(IRB) members in initial or continuing review of projects in
which they have conflicting interests. Similarly, the Final
Rule, entitled “Promoting Objectivity in Research”, sets up
the expectation that, following its implementation, “…the
design, conduct, and reporting of research…will be free from
bias resulting from Investigator financial conflicts of interest.”
PHS is an office within the Department of Health and Human
Services (HHS) that houses a number of HHS offices and agencies including, for example, the National Institutes of Health
(NIH), the Centers for Disease Control and Prevention
(CDC) and the Food and Drug Administration (FDA). One of
the key elements of the Final Rule, which applies to all PHS
funding recipients, is the redefinition of the threshold for Significant Financial Interest (SFI). The Final Rule distinguishes
between financial interests in publicly traded entities and
those in non-publicly traded entities. It considers an amount
in excess of $5,000 received from a publicly traded entity,
when aggregated over the 12 month period preceding a disclosure, for any remuneration for services and equity interests,
an SFI. Consider a scenario in which an investigator is holding
shares of Boston Scientific - a public company that makes lessinvasive medical devices – and is speaking at a variety of com-

pany events. Over the 12 months prior to a disclosure, he or
she received from Boston Scientific $3,000 in honoraria and
$3,000 in dividends due to his or her holdings. In this case,
the aggregate amount of his or her remunerations from Boston
Scientific exceeds $5,000 thus constituting an SFI.
The Final Rule is more stringent regarding equity interest
(e.g., stock, stock option, or other ownership interest) in a
non-publicly traded entity and deems any holding of such interest SFI. For example, if an investigator is among a limited
number of investors holding shares in a startup company, this
holding, regardless of size, is considered SFI. Although not
dubbed SFI, the Final Rule also requires disclosure of any reimbursed or sponsored travel.
Additionally, the Final Rule mandates that Investigators complete training on SFI. The Final Rule is not specific on the
training’s content, delivery method or documentation. It
places however the responsibility for obtaining such training
with the investigator and requires completion prior to engaging in research related to a PHS-funded award and at least
every four years.
Further, the Final Rule expands the investigator’s disclosure
requirements. In doing so defines the term “investigator’s
institutional responsibilities” as “Investigator's professional
responsibilities on behalf of the Institution, and as defined by
the Institution in its policy on financial conflicts of interest.”
The Final Rule thus means that everything and anything the
investigator does as part of his or her relationship with the
institution could, and probably should, be considered for disclosure purposes.
The requirements for reporting and public disclosure are expanded as well. Prior to expenditure of PHS research funds,
the institution must report to the funding agency any SFI of
study’s Investigator(s) it found conflicting. Prior to spending
PHS research funds and at any point thereafter, the institution
must allow public access to study investigators’ SFI disclosures
that 1) constitute FCOI, 2) are related to the specific study,
and 3) pertain to interests held by the Investigator at the time
of disclosure.

.
Continue …
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Announcements
2nd Annual BHSF Research
Pre-Conference:
April 5, 2012
BHM Auditorium
Registration & Dinner:
4-5pm
Workshop: 5:00 – 8:00pm

Educational Events
Date & Time

Event

Location

Thursday, 3/8/12
6:00 pm - 7:00 pm

Protocol Design: The
Good , the Bad and the
Ugly

BHM Auditorium

“Publishing in Scientific
Journals”, a three hour workshop present by Thomas A.
Lang, the former manager of
medical editing services for
Cleveland Clinic Foundation
and author of How to Write, Publish, & Present in the Health Sciences: A Guide For Clinicians &
Laboratory Researchers

Friday, 3/9/12
11:00 am - 12:30 pm

STATISTICS: The Basics

HH - Pineapple Room

Monday, 3/12/12
12:00 pm - 1:30 pm

Certification: Navigating
the Application Process &
Exam

BHM - Classroom 5

Wednesday, 3/14/12
8:00 am - 9:00 am

WKBH Nursing & Allied
Health Research Rounds

WKBH - Classroom 4 & 5

Friday, 3/16/12
8:00 am - 9:00 am

BHM Nursing & Allied
Health Research Rounds

BHM - Classroom 2

7th Annual BHSF Research
Conference

Thursday, 4/19/12
12:00 pm - 1:30 pm

Learning to Communicate
in Multidisciplinary Teams

BHM - Classroom 5

Friday, 4/27/12
7:30 am - 9:00 am

Research Compliance: The
Top 10 Things you Need to
Know but are Afraid to Ask

BHM - Classroom 5

Tuesday, 5/15/12
12:00 pm - 1:30 pm

NTF vs. Correction Action
Plan

Town & Country Corp
Bldg - Conference Rm 2

April 6, 2012
Kovens Conference Center
(FIU North Campus)
7:30am – 3:30pm
“A Step Forward: Moving
Research to the Bedside” by
Keynote speaker, Bradi
Granger, RN, BSN, MSN, PhD

Cont’d….
First of a New Series
“Investigator’s Exchange”
May 23, 2012
BHM Auditorium
7:30 – 8:30am
“Under-treatment of Osteoporosis and What Can
Be Done about It” presented
by Gary M. Kiebzak, PhD,
Clinical Research Administrator. This is the first of a series in
which BHSF researchers will
share their research findings
with clinicians for the purpose
of improving patient care and
implementing best practices.
We invite BHSF Investigators
from all disciplines to present
and use this as a preparatory
forum for speaking engagements.

Final Rule on FCOI in Research

This article discusses only select provisions in
42 CFR 50, Subpart F, Promoting Objectivity
in Research and in 45 CFR 94, Responsible
Prospective Contractors. The Center for
Research and Grants (CR&G), in collaboration
with additional BHSF resources, is currently
updating BHSF policies in light of the Final
Rule. As a BHSF Investigator or research team
member, you can do the following:
Inventory all financial relationships you
have in connection with your
responsibilities at BHSF. Include financial
relationships that your family members
have since, for Final Rule purposes, their
financial interests may be considered
yours.
Inquire about training on SFI. BHSF
provides training on its policy on FCOI in
research. The training on SFI referenced in
this piece is required separately and in

addition to BHSF’s training on its
policy.
Make yourself available to training
on BHSF policy on FCOI in research
when it is offered.
When requested to make an SFI
disclosure to BHSF, do so promptly
and fully.
Work closely with BHSF personnel
responsible for receiving and vetting
SFI disclosures. They can provide
guidance on this topic and help you
throughout the process.
If you need additional guidance,
contact your research lead or
Research Compliance
ResearchCompliance@baptisthealth.net

786-594-6709.
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Baptist Health South Florida
Center for Research & Grants Fact Sheet
Susan Golembeski, PhD; RN, CHRC - Assistant Vice President

Research Administration: Jean McJilton (786) 594-6704 or ResearchAdmin@baptisthealth.net
Research Administration assists with budget preparation and pricing, contract negotiation, Medicare Coverage Analysis, Humanitarian Use
Devices (HUD/HDE) and any other research administrative issue.
Clinical Trials Operations: Michelle Kirgan (786) 594-6701 or Mkirgan@baptisthealth.net
Clinical Trials Operations provides employed physicians with clinical research assistance and coordinator support which includes but is not
limited to protocol development, Institutional Review Board (IRB) submission, and regulatory guidance. Clinical Trials Operations also
provides research support to Florida International University Medical Students.
Nursing & Allied Health Research
For more information on how to get started on a research project or learn more about research, evidence-based practice, the Institutional
Review Board process, and statistics, please contact your Research Specialist.
Baptist Hospital

Eve Butler

Eveb@baptisthealth.net

Baptist Children’s Hospital

Andrea Prentiss

Andreap@baptisthealth.net

Doctors Hospital

Carolyn Lindgren

Carolynl@baptisthealth.net

Homestead & Mariners Hospital

Maria Ojeda

Mariaoj@baptisthealth.net

South Miami Hospital

Shakira Henderson

Shakiralh@baptisthealth.net

West Kendall Baptist Hospital

Tanya Judkins-Cohn

Tanyaco@baptisthealth.net

Research Fellowship Program: Tiffany Llera-Lora (786) 594-6714 or Tiffanyll@baptisthealth.net
The (EBP) Fellowship Program guides our healthcare professionals to identify clinical problems and seek the best evidence to support
changes in practice that can be facilitated by nursing and allied health. This program is designed to assist these individuals in improving the
quality of patient care they deliver through the learning and utilization of evidence-based principles at the bedside.
Library Services: (786) 662.8219 or Library@baptisthhealth.net
Any Baptist Health staff member may use library resources for the improvement of quality of care of patients. Library services support patient care, continuing education, research, publications and health care management.
Grants Division: (786) 594-6701 or Grantsinfo@baptisthealth.net
The Grants Division supports all aspects of the pre-award and post-award processes. In the Pre-Award Process we will help you to navigate
through the development of an application for government and research funding. The Post-Award process focuses on contractual compliance of your government and research award.
Research Compliance: Ofer Amit (786) 594-6709 or Ofera@baptisthealth.net
Research Compliance provides Baptist Health investigators and research teams with guidance, training, and oversight necessary to comply
with international, federal and state regulations and Baptist Health policies that govern research.
TCC Moffitt: Lisa C. Trebbi (786) 594-6705 or Lisat@baptisthealth.net
Baptist Health has partnered with Tampa-based H. Lee Moffitt Cancer Center & Research Institute in a research study, called Total Cancer
Care™ that may lead to individualized treatments for specific types of cancer. Baptist Health joins the ranks of a select number of American
healthcare institutions that have been chosen to participate in this landmark study. Baptist Hospital, South Miami Hospital, and Doctors
Hospital are the hospitals participating at this time.

Outcomes Research: Don Parris (786)594-6715 or Donp@baptisthealth.net
Investigators interested in conducting outcomes research can receive assistance in the areas of study design, research methodology,
protocol development, manuscript writing, data management and statistical analysis.
For more information visit us at http://intranet.bhssf.org/en/nursing/crg/Pages/default.aspx
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